Recombinant Elizabethkingia meningoseptica α-N-acetylgalactosaminidase 109A

Cat. No.: X23-08-YM460

Recombinant Elizabethkingia meningoseptica α-N-acetylgalactosaminidase 109A

Synonym: EmNga109A; NAGA

  • Enzyme Commission Number: 3.2.1.49
Product Size
0.25 mg; 0.50 mg; 0.75 mg; 1 mg
Price
Datasheet
MSDS
Properties
Description
Recombinant Elizabethkingia meningoseptica α-N-acetylgalactosaminidase 109A produced by Escherichia coli, is a lysosomal alpha-N-acetylgalactosaminidase that is responsible for cleaving non-reducing alpha-N-acetylgalactosaminyl moieties from glycoconjugates.
Expression System
Escherichia coli
Species
Elizabethkingia meningoseptica
Concentration
0.25 mg/mL
Form
Liquid
Purity
≥90%, determined by SDS-PAGE.
Activity
Acetylgalactosaminidases
Buffer
35 mM NaHepes buffer (pH 7.5), 750 mM NaCl, 200 mM imidazole, 3.5 mM CaCl2, and 25% (v/v) glycerol
Applications
Recombinant Elizabethkingia meningoseptica α-N-acetylgalactosaminidase 109A is useful for the investigation of Schindler's disease. It has the ability to hydrolyze 4-nitrophenyl-2-acetamido-2-deoxy-α-D-galactopyranosyl, 4-nitrophenyl-α-D-galactoside, 4-nitrophenyl-β-D-galactoside, 4-nitrophenyl-β-N-acetylgalactosamine, blood group A and AB mucin glycoproteins.
Storage
Store at -20°C.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0